Autor: |
Edgar Faber, Aida Botelho de Sousa, Ibrahim Yakoub-Agha, Irma Khvedelidze, Xavier Poiré, Ariane Boumendil, Joanna Romejko-Jarosinska, Anna Sureda, Herve Finel, Hervé Ghesquières, Kazimierz Hałaburda, Achilles Anagnostopoulos, Saad Akhtar, Carmen Martínez, Silvia Montoto, Vincenzo Pavone, Gunhan Gurman |
Rok vydání: |
2020 |
Předmět: |
|
Zdroj: |
Leukemia & Lymphoma. 61:2915-2922 |
ISSN: |
1029-2403 1042-8194 |
Popis: |
The purpose of this study was to analyze the results of second autologous hematopoietic stem cell transplantation (ASCT2) for patients with relapsed/refractory Hodgkin lymphoma (HL) after a first transplantation (ASCT1). Outcomes for 56 patients receiving an ASCT2 registered in the EBMT database were analyzed. The 4-year cumulative incidences of non-relapse mortality and disease relapse/progression were 5% and 67%, respectively. The 4-year overall survival (OS) and progression-free survival (PFS) were 62% and 28%. In univariate analysis, relapse of HL within 12 months of ASCT1 was associated with a worse OS (35% versus 76% |
Databáze: |
OpenAIRE |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|